Benzinga | Apr 13, 2021 08:07AM EDT

Credit Suisse Maintains Outperform on Arena Pharmaceuticals, Raises Price Target to $102

Credit Suisse analyst Martin Auster maintains Arena Pharmaceuticals (NASDAQ:ARNA) with a Outperform and raises the price target from $87 to $102.